<DOC>
	<DOCNO>NCT00189098</DOCNO>
	<brief_summary>Chronic suppurative otitis medium one common chronic infection child worldwide . Symptoms include otorrhea , otalgia hearing loss . In many country , treat primarily antibiotic ; country Netherlands surgical approach , tonsillectomy , adenoidectomy , placement removal tympanostomy tubes tympanomastoidectomy prefer . There however , agreement management disease . The purpose study determine effectiveness treatment sulfamethoxazole-trimethoprim 6-12 week child suffer chronic otitis medium otorrhea .</brief_summary>
	<brief_title>Effectiveness Sulfamethoxazole-trimethoprim Treatment Chronic Otitis Media</brief_title>
	<detailed_description>Chronic suppurative otitis medium one common chronic infection child worldwide . Symptoms include otorrhea , otalgia hearing loss . In many country treat primarily antibiotic ; country Netherlands surgical approach , tonsillectomy , adenoidectomy , placement removal tympanostomy tubes tympanomastoidectomy prefer . There however , agreement management disease . Co-trimoxazole inexpensive antibiotic tolerate well child , also long treatment regimen prophylaxis necessary . A previously perform retrospective study 48 child refer pediatric department otorhinolaryngology UMC Utrecht `` therapeutic resistant '' otorrhea show promising result ; 3 month follow-up , 52 % patient otorrhea free , 25 % otorrhea incidentally 23 % show sign improvement . Therefore , treatment chronic otitis medium sulfamethoxazole-trimethoprim minimum six week promise might good alternative surgical treatment . The purpose study determine effectiveness treatment sulfamethoxazole-trimethoprim 6-12 week child chronic otitis medium otorrhea 12 week .</detailed_description>
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Trimethoprim , Sulfamethoxazole Drug Combination</mesh_term>
	<mesh_term>Sulfamethoxazole</mesh_term>
	<mesh_term>Trimethoprim</mesh_term>
	<criteria>age 1 12 year otorrhea 3 month cholesteatoma know immune deficiency IgA IgG2 Down 's syndrome craniofacial anomaly cystic fibrosis immotile cilia syndrome allergy sulfamethoxazoletrimethoprim continuous use sulfamethoxazoletrimethoprim six week past six month</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>